
Top stories






EntrepreneurshipAbsa powers youth potential as headline partner of the NextGen Impact Summit in Mpumalanga
Brandscapers 3 days
More news





Logistics & Transport
The Lobito Corridor: Angola’s chance to lead in regional logistics













Sanofi-Aventis has told the U.S. Food and Drug Administration its rimonobant antiobesity drug, also sold under the Acomplia brand, brings a higher risk of suicidal thoughts than placebo, and it does not recommend the treatment for patients suffering from major depression.